Today’s pharmaceutical and medical device organizations operate amidst a highly competitive marketplace and increasing regulatory and government scrutiny. Drawing on unmatched experience, specialized knowledge and a collaborative, action-oriented approach, Huron has delivered customized financial and operational solutions that have provided significant value for more than 60 leading life sciences companies.
Our services include: Aggregate Spend Disclosure Reporting, CIA/IRO/DPA Support, Compliance Monitoring & Auditing, Fair Market Value (FMV) Determination, Government Price Reporting, Litigation & Investigation Support, and R&D Process Transformation.
Drugs and Devices Do Mix: Challenges and Opportunities for the Integrated Life Sciences Manufacturer - Presentation from Model N Rainmaker 2013
This presentation provides an overview of the strategic and organizational challenges companies in acquisition or consolidation face and considerations for avoiding both “one-size-fits-all” or highly customized approaches. » MORE
The Promise of Big Data for Gaining Insight in the Pharmaceutical Industry
Advances in Big Data promise to help pharmaceutical companies identify and segment customers, and assure compliance with federal regulations.» MORE
Drugs and Devices Do Mix: Challenges and Opportunities for the Integrated Life Sciences Manufacturer
This White Paper spells out an approach to taming the challenges of merging the operations, technical specifications, regulatory regimes, and cultures of pharmaceutical and medical device companies.» MORE